Paul A. Monach
Boston University(US)Massachusetts Department of Public Health(US)Harvard University(US)Government of the United States of America(US)VA Boston Healthcare System(US)Eastern Cooperative Oncology Group(US)Jamaica Hospital(US)Boston VA Research Institute(US)Department of Veterans Affairs(AU)
Publications by Year
Research Areas
Vasculitis and related conditions, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Otitis Media and Relapsing Polychondritis, Rheumatoid Arthritis Research and Therapies, Renal Diseases and Glomerulopathies
Most-Cited Works
- → Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis(2010)2,685 cited
- → Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis(2013)721 cited
- → Positive control of a global antioxidant defense regulon activated by superoxide-generating agents in Escherichia coli.(1990)553 cited
- → A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis(2017)383 cited
- → CD4+T cells eliminate MHC class II-negative cancer cellsin vivoby indirect effects of IFN-γ(1999)380 cited
- → The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments(2021)319 cited